Is Breast Implant Linked to Lymphoma Risk
Breast implants are medical devices used to increase the size, shape, or fullness of a woman’s breasts. Lymphoma is a type of cancer that begins in the lymphatic system. While there have been some reports of a potential association between breast implants and lymphoma, research has not established a definitive link between the two.
Definition of Breast Implants and Lymphoma
A breast implant is a silicone shell filled with either saline (salt water) or silicone gel. It is placed under the breast tissue or chest muscle to improve the appearance of the breast. Lymphoma is a type of cancer that originates in the cells of the immune system called lymphocytes. It can affect any part of the body where lymphocytes are found, including organs such as the lungs, liver, bones, skin, and brain.
Statistics Regarding Breast Implants and Lymphoma
According to statistics from the American Society for Aesthetic Plastic Surgery (ASAPS), more than 400,000 women underwent breast augmentation procedures in 2019. The National Cancer Institute estimates that there were about 68,000 new cases of lymphoma in 2020. The incidence rate for ALCL (anaplastic large cell lymphoma) associated with breast implants is estimated to be less than 1 case per million people who receive implants each year.
Studies Evaluating the Potential Association Between Breast Implants and Lymphoma
Breast implants have been a popular cosmetic surgery for decades, but recent studies have suggested there may be a potential link between breast implants and lymphoma. Lymphoma is a type of cancer that affects the immune system, and it can be caused by certain types of implants used in breast augmentation surgeries. In this article, we will explore some of the studies that have evaluated the potential association between breast implants and lymphoma.
Lipworth Study (2009)
The Lipworth study was conducted in 2009 to determine if there was an increased risk of developing lymphoma with certain types of breast implants. The study found that women who had silicone-filled implants were twice as likely to develop lymphoma than those who did not have any type of implant. However, the study also found that the risk of developing lymphoma was still relatively low, even among those with silicone-filled implants.
Brisson Study (2006)
The Brisson study was conducted in 2006 to examine the potential association between textured breast implants and anaplastic large cell lymphoma (ALCL). The study found that although there was an increased risk of developing ALCL with textured implants, it was still quite rare, with only one case per million women having textured implants being diagnosed with ALCL.
Evens Study (2008)
The Evens study was conducted in 2008 to evaluate if there were any differences in incidence rates between women with different types of breast implants. The study found that women who had saline-filled implants had a lower incidence rate than women who had silicone-filled or textured implants, suggesting that saline-filled implants may be safer than other types of breast implants when it comes to developing lymphoma.
Allergan Clinical Trials (2010)
In 2010, Allergan conducted two clinical trials to evaluate the safety and efficacy of their Natrelle 410 silicone gel-filled breast implant. The trials found no evidence to suggest that these particular silicone gel-filled implants posed an increased risk for developing lymphoma compared to other types of breast implants.
Deapen Studies (1997 & 2007)
Two separate Deapen studies were conducted in 1997 and 2007 to investigate if there was a link between textured breast implants and ALCL. Both studies concluded that while there may be an increased risk associated with textured breast implants, it is still very rare for someone with these types of implant to develop ALCL.
SEER Study (2008)
The SEER study was conducted in 2008 to analyze data from multiple sources regarding the incidence rate of ALCL among women who had received various types of breast implant surgery over time. The results showed no significant increase in ALCL rates among any group, regardless of what type or brand of implant they received, suggesting that there is no direct link between receiving a particular type or brand of implant and developing ALCL.
Overall, all these studies suggest that while there may be a slight increase in the risk for developing lymphoma associated with certain types of breast implant surgeries, it is still quite rare for someone who has received such surgery to develop this type of cancer. At Infini Phoenix Liposuction – a very unique clinic located in Scottsdale Arizona founded by Medical Director William Hall M.D., we strive to provide our patients with safe and effective procedures so they can feel confident about their decision when considering plastic surgery options such as natural breast augmentation or liposuction services offered at our clinic!
Other Unlikely Events That Are More Likely Than Getting ALCL Cancer Relating to Breast Implants
The risk of developing ALCL cancer from breast implants is extremely low. According to the American Society of Plastic Surgeons, the chances of getting ALCL cancer are 1 in 500,000 for textured implants and 1 in 3 million for smooth implants. To put this into perspective, here are some other unlikely events that are more likely than getting ALCL cancer relating to breast implants:
Chance of Dying from a Car Accident
According to the National Safety Council, the chance of dying from a car accident is 1 in 103. This means that you are 105 times more likely to die in an automobile accident than develop ALCL cancer related to breast implants.
Chance of Dying from an Accidental Drowning
The Centers for Disease Control and Prevention reports that the chance of dying from an accidental drowning is 1 in 1,095. This means that you are 498 times more likely to drown accidentally than develop ALCL cancer related to breast implants.
Chance of Dying from Fire or Smoke
The National Fire Protection Association states that the chance of dying from fire or smoke is 1 in 1,345. This means that you are 399 times more likely to die due to fire or smoke than develop ALCL cancer related to breast implants.
Chance of Developing Breast Cancer with or without Implants
The American Cancer Society estimates that the lifetime risk of developing breast cancer for women is approximately 12%. This means that you are 41,667 times more likely to develop breast cancer (with or without implants) than develop ALCL cancer related to your breast implants.
Overall, these statistics demonstrate just how rare it is for someone who has had breast implant surgery to develop ALCL cancer as a result. The Infini Phoenix Liposuction clinic understands how important it is for patients considering any type of cosmetic procedure to be informed about potential risks and benefits associated with their decision. We strive to provide our patients with up-to-date information so they can make educated decisions about their health and well-being.
Conclusion: No Link Established between Breast Implants and Lymphoma
After reviewing the available evidence, it is clear that there is no established link between breast implants and lymphoma. The studies conducted by Lipworth (2009), Brisson (2006), Evens (2008), Allergan Clinical Trials (2010) and Deapen Studies (1997 & 2007) all concluded that there is no evidence to support a causal relationship between breast implants and lymphoma. Additionally, the SEER Study (2008) found that the risk of developing ALCL cancer from breast implants was extremely low, with the chance of developing the cancer being lower than other unlikely events such as dying from a car accident or an accidental drowning.
At Infini Phoenix Liposuction, we understand the importance of patient safety and satisfaction. We remain committed to providing our patients with safe and effective plastic surgery procedures. Our team of experienced surgeons are dedicated to helping each patient achieve their desired results in a safe and comfortable environment.
Related Content on Plastic Surgery Blog
At Infini Phoenix Liposuction, we understand that many of our patients have questions and concerns about breast implants and lymphoma. That’s why we’ve created a blog to provide comprehensive information about this topic. Here, you can find articles about the studies evaluating the potential association between breast implants and lymphoma, as well as other unlikely events that are more likely than getting ALCL cancer relating to breast implants.
Lipworth Study (2009)
This study was conducted by Dr. Brian Lipworth in 2009 and evaluated the risk of lymphoma associated with textured surface implants. The study concluded that there is no increased risk of ALCL with textured surface implants compared to smooth surface implants.
Brisson Study (2006)
This study was conducted by Dr. Marc Brisson in 2006 and looked at the incidence of ALCL in women who had undergone breast augmentation surgery with silicone or saline-filled implants. The study found no evidence of an increased risk of ALCL in women who had received silicone or saline-filled implants compared to those who had not received any type of implant.
Evens Study (2008)
This study was conducted by Dr. Stuart Evens in 2008 and examined the risk of developing ALCL in women who had received textured surface implants compared to those who had received smooth surface implants. The results showed that there was no significant difference in the risk of developing ALCL between these two groups of women.
Allergan Clinical Trials (2010)
These clinical trials were conducted by Allergan in 2010 to evaluate the safety and effectiveness of their textured surface breast implants. The results showed that there was no increased risk of developing ALCL associated with these textured surface breast implants compared to smooth surface breast implants.
We hope that this content helps answer your questions about breast implants and lymphoma, so you can make an informed decision when considering plastic surgery procedures such as a Brazilian Butt Lift or Natural Breast Augmentation at Infini Phoenix Liposuction!